
    
      The evaluation of 7 new allergens on panels 2.2 and 3.2, Gold sodium thiosulfate,
      Hydrocortisone-17-butyrate, Bacitracin, Parthenolide, Methyldibromoglutaronitrile, Disperse
      blue 106, and Bronopol was the original objective of the study. The protocol was amended to
      include evaluation of 4 reformulated allergens; neomycin sulfate, potassium dichromate,
      ethylenediamne dihydrochloride and fragrance mix.
    
  